Dehaier Medical Systems (DHRM) 3.02 $DHRM
3 Stocks Under $10 to Trade for Big Breakouts
at The Street - Thu Apr 23, 12:57PM CDT
These under-$10 stocks are within range of triggering breakout trades.
DHRM: 3.02 (-0.05), TRGT: 2.43 (+0.04), SLTD: 4.54 (+0.14)
Dehaier Medical to Report 2014 Full Year Financial Results
GlobeNewswire - Wed Apr 22, 7:15AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company"
which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company plans to release its financial results for the full year of 2014 ended December 31, 2014 on Thursday, April 30, 2015.
DHRM: 3.02 (-0.05)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.15 (-0.01), DHRM: 3.02 (-0.05), IVC: 20.68 (+0.14)
Dehaier Medical Systems discloses 2014 preliminary lower net income of USD1.3m
M2 - Mon Apr 13, 6:36AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM HRM) stated on Friday it anticipates net income of USD1.3m (USD0.23 per diluted share) for the fiscal year ended 31 December 2014.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Announces Unaudited Preliminary Full Year 2014 Financial Results
GlobeNewswire - Fri Apr 10, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014.
DHRM: 3.02 (-0.05)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 27, 11:45AM CDT
DHRM: 3.02 (-0.05), GGB: 3.63 (+0.17), BMRN: 120.28 (-2.67), OLN: 30.84 (-0.10), HCHC: 11.15 (-0.05), APDN: 2.67 (unch), ZQK: 1.72 (-0.04), OXM: 79.94 (-0.16), ROLL: 75.35 (-0.58), GVP: 1.51 (+0.02), MOLG: 2.29 (-0.01), CCIH: 14.38 (-0.61), GBSN: 4.17 (-0.53), EVAR: 4.40 (+0.01), LIME: 2.83 (-0.06), CALA: 13.41 (-0.35), OHRP: 2.94 (+0.12), INPH: 1.40 (+0.02), CARV: 4.70 (-0.12), GNI: 8.10 (+0.67)
Dehaier Medical Systems Signs Strategic Cooperation Agreement With the Clinical Sleep Medicine Center of the Air Force General Hospital
GlobeNewswire - Wed Feb 11, 9:56AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a strategic cooperation agreement with the Clinical Sleep Medicine Center of the Air Force General Hospital (the "Hospital" to fully cooperate on sleep-related clinical research studies, sleep disease diagnosis and treatment, technology and equipment clinical tests, as well as public education and a sleep disorder awareness campaign. Established in October 1956 in Beijing, the Air Force General Hospital is one of the leading hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems as well.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Showcases Its Wearable Sleep Respiratory Solution at Jiangxi Sleep and Health Forum
GlobeNewswire - Thu Jan 22, 9:31AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that representatives from the Company recently participated in the Jiangxi Province Sleep and Health Forum (the "Jiangxi Sleep Forum" to promote the Company's wearable sleep respiratory product and solution.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to Leading Physical Examination Chain
GlobeNewswire - Mon Jan 12, 8:16AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by Ciming Aoya Hospital, a subsidiary of Ciming Healthcare Group (the "Ciming Group" . The Company's wearable sleep respiratory solution features a full range of innovative products and services, including working stations, cloud-based diagnostic and analysis software, watch-sized sleep diagnostic and monitoring devices, and PPG sensors. Established in 2004, the Ciming Group is one of the three largest physical examination chains in China and provides comprehensive screening, diagnostic, treatment, and health management services for nearly two million people each year through its 83 subsidiaries and affiliates and over 100 third party cooperative organizations across China.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Attends Two Premier Sleep Conferences
GlobeNewswire - Wed Dec 10, 8:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it attended the inaugural Western Sleep Conference (the "WSC" which took place December 5-6, 2014 in Chengdu, Sichuan Province. Sponsored by the Chinese Sleep Research Society, the WSC is a scientific and clinical meeting for sleep physicians, researchers, and industry practitioners, featuring panels, roundtables, workshops and an exhibition hall focused on the latest development in sleep research and sleep medicine and devices. The WSC is hosted by West China Hospital, Sichuan University ("West China Hospital" , one of the largest hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems.
DHRM: 3.02 (-0.05)
Dehaier Medical and WideMed Broaden and Extend Exclusive Strategic Partnership for Six More Years
GlobeNewswire - Thu Nov 20, 9:12AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a new software license and strategic cooperation agreement (the "New Agreement" with Israel-based WideMed Technologies Ltd. ("WideMed" during the MEDICA trade fair ("MEDICA" , which took place November 16 -19, 2014 in Dusseldorf, Germany.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to 2nd Batch of 30 Hospitals and Medical Examination Centers
GlobeNewswire - Thu Nov 06, 8:45AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by an additional 26 major hospitals and 4 medical examination centers in Beijing, Tianjin, Shanxi, Hebei, Anhui, Hubei, Shandong, Inner Mongolia, and Gansu provinces. This, combined with the 22 hospitals and 6 medical examination centers announced last month, brings the total count of hospitals and medical examination centers equipped with the Company's wearable sleep respiratory solution systems to 58 in 14 provinces and cities throughout the country. The Company's wearable sleep respiratory solution features a full range of products and services, including working stations, software, watch-sized sleep diagnostic devices, and PPG sensors. Dehaier's product line enables Obstructive Sleep Apnea Syndrome ("OSAS" diagnosis, CPAP treatment, curative effect evaluation, and other related services.
DHRM: 3.02 (-0.05)
Dehaier Medical Systems posts lesser net income of approximately USD1.40m for the first half in 2014
M2 - Fri Oct 17, 7:13AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM HRM) stated on Friday that after deducting non-controlling interest, net income of approximately USD1.40m (USD0.26 per diluted share) was reported for the six months ended 30 June 2014.
DHRM: 3.02 (-0.05)
Dehaier Medical 1H revenues off 25%
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 6:21AM CDT
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Announces First Half 2014 Financial Results
GlobeNewswire - Fri Oct 17, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the six months ended June 30, 2014.
DHRM: 3.02 (-0.05)
Dehaier Medical to Report 2014 First Half Year Financial Results October 17
GlobeNewswire - Mon Oct 13, 9:30PM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company plans to release its financial results for the first half of 2014 ended June 30, 2014 on Friday, October 17, 2014.
DHRM: 3.02 (-0.05)
Dehaier Provides Wearable OSAS Solutions to Twenty-Eight Hospitals and Medical Examination Centers in China
GlobeNewswire - Thu Oct 02, 8:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that twenty-eight medical examination centers and hospitals in China have introduced Dehaier's wearable sleep respiratory technology systems to provide Obstructive Sleep Apnea Syndrome ("OSAS" diagnosis, CPAP treatment, curative effect evaluation and other related services.
DHRM: 3.02 (-0.05)
Dehaier Wins Multiple Medical Equipment Procurement Projects for Top-Tier Hospitals
GlobeNewswire - Wed Sep 24, 8:21AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it cooperated with several large medical enterprises in multiple medical equipment procurement projects for top-tier hospitals in China and successfully secured purchasing orders of medical equipment including anaesthesia machines, defibrillators, color doppler ultrasound machines, magnetic resonance imaging machines, computed tomography machines and video bronchoscopes. The projects bidding amount totaled $11 million.
DHRM: 3.02 (-0.05)
Nasdaq stocks posting largest percentage decreases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
HELE: 79.16 (+0.70), RESN: 3.90 (+0.06), DHRM: 3.02 (-0.05), PACB: 5.76 (-0.14), PHII: 31.74 (-0.26), CONN: 30.85 (+0.15), RPRX: 8.43 (-0.06), DEPO: 27.65 (+0.36), PHIIK: 33.14 (+0.05), HMSY: 17.30 (-0.58), SVA: 5.10 (unch), DGLY: 13.88 (+0.39)
3 Stocks Under $10 to Trade for Big Breakouts
at The Street - Thu Apr 23, 12:57PM CDT
These under-$10 stocks are within range of triggering breakout trades.
DHRM: 3.02 (-0.05), TRGT: 2.43 (+0.04), SLTD: 4.54 (+0.14)
Dehaier Medical to Report 2014 Full Year Financial Results
GlobeNewswire - Wed Apr 22, 7:15AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company plans to release its financial results for the full year of 2014 ended December 31, 2014 on Thursday, April 30, 2015. DHRM: 3.02 (-0.05)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.15 (-0.01), DHRM: 3.02 (-0.05), IVC: 20.68 (+0.14)
Dehaier Medical Systems discloses 2014 preliminary lower net income of USD1.3m
M2 - Mon Apr 13, 6:36AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM
HRM) stated on Friday it anticipates net income of USD1.3m (USD0.23 per diluted share) for the fiscal year ended 31 December 2014. DHRM: 3.02 (-0.05)
Dehaier Medical Systems Announces Unaudited Preliminary Full Year 2014 Financial Results
GlobeNewswire - Fri Apr 10, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014. DHRM: 3.02 (-0.05)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 27, 11:45AM CDT
DHRM: 3.02 (-0.05), GGB: 3.63 (+0.17), BMRN: 120.28 (-2.67), OLN: 30.84 (-0.10), HCHC: 11.15 (-0.05), APDN: 2.67 (unch), ZQK: 1.72 (-0.04), OXM: 79.94 (-0.16), ROLL: 75.35 (-0.58), GVP: 1.51 (+0.02), MOLG: 2.29 (-0.01), CCIH: 14.38 (-0.61), GBSN: 4.17 (-0.53), EVAR: 4.40 (+0.01), LIME: 2.83 (-0.06), CALA: 13.41 (-0.35), OHRP: 2.94 (+0.12), INPH: 1.40 (+0.02), CARV: 4.70 (-0.12), GNI: 8.10 (+0.67)
Dehaier Medical Systems Signs Strategic Cooperation Agreement With the Clinical Sleep Medicine Center of the Air Force General Hospital
GlobeNewswire - Wed Feb 11, 9:56AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a strategic cooperation agreement with the Clinical Sleep Medicine Center of the Air Force General Hospital (the "Hospital" to fully cooperate on sleep-related clinical research studies, sleep disease diagnosis and treatment, technology and equipment clinical tests, as well as public education and a sleep disorder awareness campaign. Established in October 1956 in Beijing, the Air Force General Hospital is one of the leading hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems as well. DHRM: 3.02 (-0.05)
Dehaier Medical Systems Showcases Its Wearable Sleep Respiratory Solution at Jiangxi Sleep and Health Forum
GlobeNewswire - Thu Jan 22, 9:31AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that representatives from the Company recently participated in the Jiangxi Province Sleep and Health Forum (the "Jiangxi Sleep Forum" to promote the Company's wearable sleep respiratory product and solution. DHRM: 3.02 (-0.05)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to Leading Physical Examination Chain
GlobeNewswire - Mon Jan 12, 8:16AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by Ciming Aoya Hospital, a subsidiary of Ciming Healthcare Group (the "Ciming Group" . The Company's wearable sleep respiratory solution features a full range of innovative products and services, including working stations, cloud-based diagnostic and analysis software, watch-sized sleep diagnostic and monitoring devices, and PPG sensors. Established in 2004, the Ciming Group is one of the three largest physical examination chains in China and provides comprehensive screening, diagnostic, treatment, and health management services for nearly two million people each year through its 83 subsidiaries and affiliates and over 100 third party cooperative organizations across China. DHRM: 3.02 (-0.05)
Dehaier Medical Systems Attends Two Premier Sleep Conferences
GlobeNewswire - Wed Dec 10, 8:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it attended the inaugural Western Sleep Conference (the "WSC" which took place December 5-6, 2014 in Chengdu, Sichuan Province. Sponsored by the Chinese Sleep Research Society, the WSC is a scientific and clinical meeting for sleep physicians, researchers, and industry practitioners, featuring panels, roundtables, workshops and an exhibition hall focused on the latest development in sleep research and sleep medicine and devices. The WSC is hosted by West China Hospital, Sichuan University ("West China Hospital" , one of the largest hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems. DHRM: 3.02 (-0.05)
Dehaier Medical and WideMed Broaden and Extend Exclusive Strategic Partnership for Six More Years
GlobeNewswire - Thu Nov 20, 9:12AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a new software license and strategic cooperation agreement (the "New Agreement" with Israel-based WideMed Technologies Ltd. ("WideMed" during the MEDICA trade fair ("MEDICA" , which took place November 16 -19, 2014 in Dusseldorf, Germany. DHRM: 3.02 (-0.05)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to 2nd Batch of 30 Hospitals and Medical Examination Centers
GlobeNewswire - Thu Nov 06, 8:45AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by an additional 26 major hospitals and 4 medical examination centers in Beijing, Tianjin, Shanxi, Hebei, Anhui, Hubei, Shandong, Inner Mongolia, and Gansu provinces. This, combined with the 22 hospitals and 6 medical examination centers announced last month, brings the total count of hospitals and medical examination centers equipped with the Company's wearable sleep respiratory solution systems to 58 in 14 provinces and cities throughout the country. The Company's wearable sleep respiratory solution features a full range of products and services, including working stations, software, watch-sized sleep diagnostic devices, and PPG sensors. Dehaier's product line enables Obstructive Sleep Apnea Syndrome ("OSAS" diagnosis, CPAP treatment, curative effect evaluation, and other related services. DHRM: 3.02 (-0.05)
Dehaier Medical Systems posts lesser net income of approximately USD1.40m for the first half in 2014
M2 - Fri Oct 17, 7:13AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM
HRM) stated on Friday that after deducting non-controlling interest, net income of approximately USD1.40m (USD0.26 per diluted share) was reported for the six months ended 30 June 2014. DHRM: 3.02 (-0.05)
Dehaier Medical 1H revenues off 25%
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 6:21AM CDT
DHRM: 3.02 (-0.05)
Dehaier Medical Systems Announces First Half 2014 Financial Results
GlobeNewswire - Fri Oct 17, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the six months ended June 30, 2014. DHRM: 3.02 (-0.05)
Dehaier Medical to Report 2014 First Half Year Financial Results October 17
GlobeNewswire - Mon Oct 13, 9:30PM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company plans to release its financial results for the first half of 2014 ended June 30, 2014 on Friday, October 17, 2014. DHRM: 3.02 (-0.05)
Dehaier Provides Wearable OSAS Solutions to Twenty-Eight Hospitals and Medical Examination Centers in China
GlobeNewswire - Thu Oct 02, 8:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that twenty-eight medical examination centers and hospitals in China have introduced Dehaier's wearable sleep respiratory technology systems to provide Obstructive Sleep Apnea Syndrome ("OSAS" diagnosis, CPAP treatment, curative effect evaluation and other related services. DHRM: 3.02 (-0.05)
Dehaier Wins Multiple Medical Equipment Procurement Projects for Top-Tier Hospitals
GlobeNewswire - Wed Sep 24, 8:21AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it cooperated with several large medical enterprises in multiple medical equipment procurement projects for top-tier hospitals in China and successfully secured purchasing orders of medical equipment including anaesthesia machines, defibrillators, color doppler ultrasound machines, magnetic resonance imaging machines, computed tomography machines and video bronchoscopes. The projects bidding amount totaled $11 million. DHRM: 3.02 (-0.05)
Nasdaq stocks posting largest percentage decreases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
HELE: 79.16 (+0.70), RESN: 3.90 (+0.06), DHRM: 3.02 (-0.05), PACB: 5.76 (-0.14), PHII: 31.74 (-0.26), CONN: 30.85 (+0.15), RPRX: 8.43 (-0.06), DEPO: 27.65 (+0.36), PHIIK: 33.14 (+0.05), HMSY: 17.30 (-0.58), SVA: 5.10 (unch), DGLY: 13.88 (+0.39)
